Provided by Tiger Trade Technology Pte. Ltd.

Olema Pharmaceuticals, Inc.

10.91
+0.48004.60%
Post-market: 10.910.00000.00%19:30 EDT
Volume:799.92K
Turnover:8.73M
Market Cap:950.88M
PE:-5.12
High:11.02
Open:10.60
Low:10.60
Close:10.43
52wk High:36.26
52wk Low:5.36
Shares:87.16M
Float Shares:71.89M
Volume Ratio:0.76
T/O Rate:1.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1289
EPS(LYR):-1.8700
ROE:-52.74%
ROA:-31.82%
PB:2.21
PE(LYR):-5.83

Loading ...

Olema Oncology Appoints Prakash Raman, Ph.d., to Board of Directors

THOMSON REUTERS
·
Apr 30

Press Release: Olema Oncology Appoints Prakash Raman, Ph.D., to Board of Directors

Dow Jones
·
Apr 30

Olema Pharmaceuticals (OLMA) Valuation Check After New Palazestrant And OP-3136 Preclinical Results

Simply Wall St.
·
Apr 27

Olema Oncology to present initial clinical data for OP-3136 at ASCO

TIPRANKS
·
Apr 22

Olema to present initial Phase 1 OP-3136 clinical data at ASCO meeting

Reuters
·
Apr 22

Olema Pharmaceuticals (OLMA) Is Up 5.6% After Preclinical Data Highlight Deeper ER Blockade Potential

Simply Wall St.
·
Apr 21

A Look At Olema Pharmaceuticals (OLMA) Valuation After New Preclinical Breast Cancer Data

Simply Wall St.
·
Apr 20

Olema Oncology announces preclinical data for Palazestrant

TIPRANKS
·
Apr 18

Olema says OP-3136 Phase 1 trial enrolls patients in breast cancer study

Reuters
·
Apr 18

Olema grants inducement stock options for 188,500 shares to four new employees

Reuters
·
Apr 03

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Apr 03

A Look At Olema Pharmaceuticals (OLMA) Valuation After Earnings And New Shelf Registration Filing

Simply Wall St.
·
Mar 30

Olema Pharmaceuticals Initiated at Peer Perform by Wolfe Research

Dow Jones
·
Mar 27

Olema Oncology initiated with a Peer Perform at Wolfe Research

TIPRANKS
·
Mar 27

LifeSci Capital Reaffirms Their Buy Rating on Olema Pharmaceuticals (OLMA)

TIPRANKS
·
Mar 21

Olema Pharmaceuticals Coverage Assumed by Jefferies at Buy

Dow Jones
·
Mar 20

Olema Pharmaceuticals Is Maintained at Overweight by JP Morgan

Dow Jones
·
Mar 18

Stock Track | Olema Pharmaceuticals Plummets 5.01% Intraday After Goldman Sachs Slashes Price Target

Stock Track
·
Mar 18

Olema Oncology price target raised to $58 from $55 at JPMorgan

TIPRANKS
·
Mar 18

Olema Oncology price target lowered to $27 from $38 at Goldman Sachs

TIPRANKS
·
Mar 18